Core Scientific, Inc. (CORZ)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Core Scientific's Meltdown Over, Accelerating AI Monetization From FY 2026
Core Scientific's transition from Bitcoin mining to High Performance Computing has been extremely strategic, allowing them to capitalize on the AI-driven data center boom. Its Colocation Services now deliver higher gross margins of 26% compared to its mining operations and are expected to reach up to ~80% on new CRWV contracts. CORZ-CRWV's partnership notably reduces CORZ's capital/balance sheet burden and secures its AI growth opportunities over the next decade.
Core Scientific: Undervalued Powerhouse In The AI Data Center Era
Core Scientific is rapidly transitioning from BTC mining to a leading AI HPC infrastructure provider, leveraging its 1.3 GW data center footprint. Initiate CORZ as a strong buy, citing undervaluation versus AI peers and significant upside as the market misprices it as a BTC miner. CORZ's AI hosting contracts deliver high-margin, recurring revenues, with projected explosive revenue growth and expanding gross margins through 2030.
A Failed Acquisition Is The Best Thing That's Happened To Core Scientific
Core Scientific, Inc. shareholders rejected a $9B CoreWeave offer Thursday. We think this is the best thing that could've happened to Core Scientific. We see the potential for CORZ to grow into the valuation of its landlord peer group. There is more value in Core Scientific's uncontracted power capacity, and ballooning AI infrastructure demand can work in favor of leasing out its current 1.3 GW and potential 1 GW capacity.
Core Scientific, Inc. (CORZ) Discusses Shareholder Vote and Termination of Proposed Merger Transcript
Core Scientific, Inc. ( CORZ ) Discusses Shareholder Vote and Termination of Proposed Merger October 30, 2025 11:30 AM EDT Company Participants Jon Charbonneau - Vice President of Investor Relations Adam Sullivan - CEO, President & Director Matt Brown - Chief Operating Officer Jim Nygaard - Chief Financial Officer Conference Call Participants Darren Aftahi - ROTH Capital Partners, LLC, Research Division Jonathan Petersen - Jefferies LLC, Research Division Brett Knoblauch - Cantor Fitzgerald & Co., Research Division Joseph Flynn Joseph Vafi - Canaccord Genuity Corp., Research Division Kevin Dede - H.C. Wainwright & Co, LLC, Research Division Brian Dodso Paul Golding - Macquarie Research Gregory Lewis - BTIG, LLC, Research Division Michael Donovan - Compass Point Research & Trading, LLC, Research Division Timothy Horan - Oppenheimer & Co. Inc., Research Division Stephen Glagola - JonesTrading Institutional Services, LLC, Research Division Presentation Operator Greetings, and welcome to Core Scientific Investor Update Call.
Core Scientific: Walking Away
Core Scientific trades at all-time highs ahead of a key shareholder vote on the proposed CoreWeave merger. The fixed exchange ratio undervalues CORZ shares, with the market speculating the deal will be blocked as peers like IREN and WULF outperform. Despite mixed Q3 results, CORZ's growth prospects in AI infrastructure and potential for new contracts remain strong if the merger is canceled.
Core Scientific shareholders reject takeover offer from CoreWeave, merger deal ends
Core Scientific Inc on Thursday terminated its merger agreement with CoreWeave after Core Scientific shareholders voted against the proposal. In July, CoreWeave struck an agreement to acquire Core Scientific in an all-stock deal valued at $9 billion.
Core Scientific's board urges shareholders to vote for CoreWeave deal
Core Scientific's board urged its shareholders on Wednesday to vote for the company's proposed sale to CoreWeave.
Core Scientific, Inc. (CORZ) Upgraded to Buy: What Does It Mean for the Stock?
Core Scientific, Inc. (CORZ) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Core Scientific, Inc. (CORZ) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Core Scientific, Inc. (CORZ) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Core Scientific, Inc. (CORZ) Reports Q2 Loss, Lags Revenue Estimates
Core Scientific, Inc. (CORZ) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.04 per share a year ago.
Core Scientific shareholders push back on CoreWeave's $9B takeover offer: report
CoreWeave (NASDAQ:CRWV)'s $9 billion all-stock acquisition of data center operator Core Scientific (NASDAQ:CORZ) is facing shareholder resistance, with major investors saying they may vote against the deal unless its terms are updated, according to a Financial Times report. The FT, citing people familiar with the matter, said the pushback stems from concerns that the current offer undervalues Core Scientific and exposes its investors to unnecessary downside risk.
Core Scientific shareholders balk at terms of CoreWeave merger offer, FT reports
CoreWeave's $9 billion deal to buy data centre landlord Core Scientific is facing a potential revolt, with some top shareholders of the target company arguing it could leave them short-changed, the Financial Times reported on Tuesday.
